Senior Director, Corporate Controller
Amy Chen is the Corporate Controller at Kriya Therapeutics. Ms. Chen joins Kriya from Jazz Pharmaceuticals where she as the Director of Accounting, supporting all aspects of the company’s U.S. accounting operations and related SOX compliance. Before Jazz, she was the Assistant Controller at Natera, then a biotech startup, where she played a key role in the company’s accounting readiness for its initial S-1 filing. Ms. Chen has also held roles in both technical accounting and BU finance. Ms. Chen started her career in public accounting with Deloitte and subsequently Ernst & Young, serving both public and private audit clients across various industries. She is a Certified Public Accountant actively licensed in the state of California.
Ms. Chen received her master’s degree in economics from Southern Illinois University at Carbondale and her master’s degree in accounting from the University of Georgia. Ms. Chen receive her bachelor’s degree in economics from Zhongnan University of Economics of Law in China.